Status:
UNKNOWN
Clinical, Radiological, Histologic and Molecular Features of a Cohort of Melanocytic Tumors of the Central Nervous System
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Meningeal Melanocytoma
Meningeal Melanomatosis
Eligibility:
All Genders
Brief Summary
Primary melanocytic tumors of the central nervous system are rare lesions and occur develop from leptomeningeal melanocytes. The WHO classification of tumors of the central nervous system in its most ...
Detailed Description
The discovery within the CNS of a tumor of melanocytic nature requires the realization an exhaustive assessment (dermatological examination, whole body imaging), especially in the event of signs histo...
Eligibility Criteria
Inclusion
- Patient with a primitive meningeal melanocytic tumor
Exclusion
- Patient with metastatic extrameningeal melanoma
Key Trial Info
Start Date :
January 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05984108
Start Date
January 1 2023
End Date
June 1 2024
Last Update
August 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nancy University Hospital Center
Nancy, France, 54500